Bacteremia Clinical Trials in Calgary, Alberta
6 recruitingCalgary, Alberta, Canada
Showing 1–6 of 6 trials
Recruiting
Phase 2
Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia
Staphylococcus Aureus BacteremiaStaphylococcus Aureus EndocarditisStaphylococcus Aureus Septicemia+1 more
Todd C. Lee MD MPH FIDSA60 enrolled5 locationsNCT04886284
Recruiting
Not Applicable
A Platform Trial for Gram Negative Bloodstream Infections
Gram-negative Bacteremia
Sunnybrook Health Sciences Centre2,500 enrolled39 locationsNCT06537609
Recruiting
Phase 4
Staphylococcus Aureus Network Adaptive Platform Trial
Staphylococcus Aureus Bacteremia
University of Melbourne8,000 enrolled151 locationsNCT05137119
Recruiting
Phase 4
PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN)
Enterobacteriaceae InfectionsBacteremiaBeta Lactam Resistant Bacterial Infection
Rambam Health Care Campus1,084 enrolled14 locationsNCT03671967
Recruiting
Not Applicable
Optimizing the Management of Staphylococcus Aureus Bacteremia (OPTIMUS-SAB)
Staph Aureus Bacteremia
University of Alberta1,800 enrolled101 locationsNCT06338176
Recruiting
Not Applicable
Evaluating Simplified Layered Consent for Clinical Trials
Staphylococcus Aureus Bacteremia
Sunnybrook Health Sciences Centre346 enrolled6 locationsNCT06168474